Infliximab: an alternative treatment for refractory immune thrombocytopenic purpura related to Crohn's disease?
Lazaraki
Georgia
G
Metallidis
Simeon
S
Giannoulis
Kleanthis
K
Tarpagos
Anestis
A
Germanidis
Georgios
G
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000209:etiology; D016879:Salvage Therapy
D000911:Antibodies, Monoclonal; D000069285:Infliximab